Role of PON3 in regulating renal Na+ and K+ homeostasis

Information

  • Research Project
  • 10338835
  • ApplicationId
    10338835
  • Core Project Number
    R01DK130901
  • Full Project Number
    1R01DK130901-01
  • Serial Number
    130901
  • FOA Number
    PA-20-185
  • Sub Project Id
  • Project Start Date
    9/15/2021 - 3 years ago
  • Project End Date
    8/31/2026 - a year from now
  • Program Officer Name
    KETCHUM, CHRISTIAN J
  • Budget Start Date
    9/15/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/15/2021 - 3 years ago

Role of PON3 in regulating renal Na+ and K+ homeostasis

ABSTRACT The mammalian paraoxonase (PON) family consists of three highly conserved members (PON1, PON2 and PON3) with unique anti-oxidative and anti-atherosclerotic properties. PON1 and 2 have been implicated in blood pressure (BP) regulation. While the role of PON3 in regulating BP has not been investigated, it is expressed in the aldosterone-sensitive distal nephron where the fine tuning of Na+ absorption and K+ secretion occurs. PONs share key structural and functional features with MEC-6, an endoplasmic reticulum-resident chaperone of C. elegans. MEC-6 is required for proper folding, assembly, and surface expression of the mechanosensitive degenerin channel in touch receptor neurons. The chaperon function is conserved between mammalian PONs and C. elegans MEC-6. We have previously shown that both PON2 and PON3 regulate functional expression of the epithelial Na+ channel (ENaC), a member of the ENaC/degenerin family of ion channels. ENaC mediates the rate-limiting step of Na+ reabsorption in distal nephron and has a key role in volume and BP control. While the constitutive K+ secretion is conducted by the renal outer medullary K+ (ROMK) channels, ENaC-dependent and flow-induced K+ secretion is mediated by the large conductance K+ (BK) channels. In the preliminary studies, we found that Pon3 KO mice have higher ENaC activity and enhanced amiloride-sensitive natriuresis, suggesting ENaC functional expression is upregulated in the absence of PON3. In addition, we have identified BK channel as a novel target of PON3. When expressed in HEK293 cells, PON3 interacted with BK ? subunit to reduce its surface expression and channel activity. Our proposed studies will define mechanisms by which PON3 functions as a chaperone in the regulation of ENaC and BK expression. We will determine the consequences of deleting PON3 in renal Na+ and K+ handling and BP control in mice. Successful completion our proposed studies will enhance our understanding of the mechanisms by which PONs function as chaperones and their physiological roles in kidney function and BP control.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R01
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
    200000
  • Indirect Cost Amount
    113000
  • Total Cost
    313000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    847
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIDDK:313000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    KUFD
  • Study Section Name
    Kidney and Urological Systems Function and Dysfunction Study Section
  • Organization Name
    UNIVERSITY OF PITTSBURGH AT PITTSBURGH
  • Organization Department
    INTERNAL MEDICINE/MEDICINE
  • Organization DUNS
    004514360
  • Organization City
    PITTSBURGH
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    152133203
  • Organization District
    UNITED STATES